NCT04188418 2026-02-19
Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Active not recruiting
Clinical Trials
14 trialsNCT06349668 2026-02-05
SMILe
University Hospital, Linkoeping
Phase 3 Recruiting
NCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended
NCT03823534 2025-10-15
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
St. Louis University
Phase 3 Recruiting
NCT05236647 2025-03-06
SIM
University Hospital, Akershus
Phase 3 Completed
NCT05325164 2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3 Withdrawn
NCT03825887 2021-08-02
PCA
Children's Cancer Hospital Egypt 57357
Phase 3 Completed
NCT01318161 2021-02-16
EPICOL
Örebro University, Sweden
Phase 3 Terminated
NCT02591017 2018-11-13
ONKEMI
University Hospital, Basel, Switzerland
Phase 3 Terminated
NCT02687347 2016-09-20
UDOME
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 3 Unknown
NCT00634010 2016-05-09
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00201539 2015-04-08
Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients
Norwegian University of Science and Technology
Phase 3 Completed
NCT01825993 2013-04-08
2013/004
Corporacion Parc Tauli
Phase 3 Unknown
NCT01367418 2012-03-19
AIMS
Örebro University, Sweden
Phase 3 Completed